Spurred by the vast potential of artificial intelligence (AI) and machine learning (ML) technologies, many countries are evaluating whether existing
Continue Reading Will Divergent Copyright Laws Between the US and UK Influence Where You Do Business as an Artificial Intelligence Company?
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating
Continue Reading Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration
On April 13, 2022, the European Commission submitted a proposed regulation on the protection of Geographical Indications for Craft and
Continue Reading Geographical Indications in the EU: A Step Forward in the Protection of Traditional Artisanal Skills
In light of Elon Musk’s recent offer to buy Twitter, Inc. (“Twitter”) there has been a resurgence in the desire
Continue Reading Increased Innovation in Decentralized Social Networks Space Spurred By Ownership Uncertainty of Traditional Platforms
Background
The food tech industry has been rapidly growing in recent years with the rise in popularity of alternative (“alt-“)
Continue Reading Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement
In the first major patent infringement lawsuit in the mRNA space, on February 28, 2022, Arbutus Biopharma Corporation (“Arbutus”) and
Continue Reading Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space
On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells
On January 4, 2022, Judge Andrews from the United States District Court for the District of Delaware denied Sarepta Therapeutics,
Continue Reading Delaware Judge Denies Sarepta Protection Under Hatch-Waxman “Safe Harbor”
In April of 2021, we provided a three-part series relating to the IP and Competitive Landscape for the mRNA market.
Continue Reading mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook